ANGN · Categories · Form 3
ANGN - SEC Form 3 initial insider statements
Angion Biomedica Corp. (ANGN) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for ANGN
- SEC Form 3: New insider Chudnovsky Yekaterina claimed ownership of 702,639 shares3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3: New insider Haqq Christopher claimed ownership of 31,981 shares3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Demuth Peter3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Segal Assaf3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Ruffolo Robert R3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Matthies Annette3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Adams Julian3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3: New insider Connelly Robert claimed ownership of 46,970 shares3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Ashe Carol Gail3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3 filed by new insider Piekos Brian3 - Elicio Therapeutics, Inc. (0001601485) (Issuer)
- SEC Form 3: EISA-ABC LLC claimed ownership of 3,654,637 units of Common Stock3 - Angion Biomedica Corp. (0001601485) (Issuer)